Cargando…
Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes
Although several pharmacogenetic (PGx) predispositions affecting drug efficacy and safety are well established, drug selection and dosing as well as clinical trials are often performed in a non-pharmacogenetically-stratified manner, ultimately burdening healthcare systems. Pre-emptive PGx testing of...
Autores principales: | Caspar, Sylvan M., Schneider, Timo, Meienberg, Janine, Matyas, Gabor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178228/ https://www.ncbi.nlm.nih.gov/pubmed/32225115 http://dx.doi.org/10.3390/ijms21072308 |
Ejemplares similares
-
Clinical sequencing: is WGS the better WES?
por: Meienberg, Janine, et al.
Publicado: (2016) -
Variant filtering, digenic variants, and other challenges in clinical sequencing: a lesson from fibrillinopathies
por: Najafi, Arash, et al.
Publicado: (2019) -
Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
por: Gorosabel, Maria C, et al.
Publicado: (2020) -
Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
por: Tilleman, Laurentijn, et al.
Publicado: (2022) -
Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences
por: Lee, Seung‐been, et al.
Publicado: (2019)